Alex Y. Chang

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B.

Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B.

Journal: Journal of clinical and translational hepatology

Published: May 01, 2020

Real world experience on treatment, outcome and toxicity of crizotinib in patients with anaplastic lymphoma kinase positive advanced non-small cell lung cancer.

Real world experience on treatment, outcome and toxicity of crizotinib in patients with anaplastic lymphoma kinase positive advanced non-small cell lung cancer.

Journal: Journal of thoracic disease

Published: October 28, 2019

Development of a Liposomal Formulation of Acetyltanshinone IIA for Breast Cancer Therapy.

Development of a Liposomal Formulation of Acetyltanshinone IIA for Breast Cancer Therapy.

Journal: Molecular pharmaceutics

Published: August 08, 2019

Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.

Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 16, 2018

Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia.

Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia.

Journal: Science translational medicine

Published: May 12, 2017

Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: a study of formulation optimization, toxicity, and pharmacokinetics.

Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: a study of formulation optimization, toxicity, and pharmacokinetics.

Journal: Oncotarget

Published: November 30, 2016

Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer.

Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer.

Journal: BMJ open gastroenterology

Published: April 08, 2016

Brain Metastases from Breast Cancer and Response to Treatment with Eribulin: A Case Series.

Brain Metastases from Breast Cancer and Response to Treatment with Eribulin: A Case Series.

Journal: Breast cancer : basic and clinical research

Published: October 23, 2014

In-vitro growth inhibition of chemotherapy and molecular targeted agents in hepatocellular carcinoma.

In-vitro growth inhibition of chemotherapy and molecular targeted agents in hepatocellular carcinoma.

Journal: Anti-cancer drugs

Published: November 29, 2012

Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells.

Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells.

Journal: BMC cancer

Published: November 07, 2012

Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC.

Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 22, 2010

The role of gefitinib in the management of Asian patients with non-small cell lung cancer.

The role of gefitinib in the management of Asian patients with non-small cell lung cancer.

Journal: Expert opinion on investigational drugs

Published: March 07, 2008

Showing 1-12 of 14

Last Updated: 09/26/2026